This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The University of North Carolina at Chapel Hill, Trinity Capital, Inc., as Administrative Agent and Collateral Agent. Active years: 2025-2026.
Company Filing History:
1 out of 1,325 
1 out of 1 Years Active: 2025-2026
Title: Rachel Bailey: Innovator in Genetic Research
Introduction
Rachel Bailey is a prominent inventor based in Trophy Club, TX (US). She has made significant contributions to the field of genetic research, particularly in the area of optimized gene expression.
Latest Patents
Rachel holds a patent for "Optimized FIG4 genes and expression cassettes and their use." This invention relates to polynucleotides comprising optimized open reading frame (ORF) sequences, vectors that include these sequences, and methods for delivering the ORF to a cell or subject. The invention aims to treat disorders associated with aberrant expression of a gene or the aberrant activity of a gene product, such as Charcot-Marie-Tooth disease type 4J (CMT4J). She has 1 patent to her name.
Career Highlights
Rachel is affiliated with the University of North Carolina at Chapel Hill, where she continues her research and innovation in genetic studies. Her work has the potential to impact the treatment of genetic disorders significantly.
Collaborations
Rachel collaborates with Steven Gray, a fellow researcher, to advance their understanding and application of genetic therapies.
Conclusion
Rachel Bailey is a dedicated inventor whose work in optimizing gene expression holds promise for treating genetic disorders. Her contributions to the field are noteworthy and continue to inspire future innovations.